Barclays’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-25,084
| Closed | -$3K | – | 4547 |
|
2018
Q4 | $3K | Sell |
25,084
-166,403
| -87% | -$19.9K | ﹤0.01% | 3896 |
|
2018
Q3 | $326K | Sell |
191,487
-151,302
| -44% | -$258K | ﹤0.01% | 2832 |
|
2018
Q2 | $596K | Sell |
342,789
-262,609
| -43% | -$457K | ﹤0.01% | 2172 |
|
2018
Q1 | $1.11M | Buy |
605,398
+550,954
| +1,012% | +$1.01M | ﹤0.01% | 1728 |
|
2017
Q4 | $121K | Buy |
54,444
+24,778
| +84% | +$55.1K | ﹤0.01% | 2914 |
|
2017
Q3 | $86K | Buy |
29,666
+14,499
| +96% | +$42K | ﹤0.01% | 2752 |
|
2017
Q2 | $68K | Sell |
15,167
-13,183
| -47% | -$59.1K | ﹤0.01% | 2912 |
|
2017
Q1 | $132K | Buy |
28,350
+868
| +3% | +$4.04K | ﹤0.01% | 2714 |
|
2016
Q4 | $167K | Buy |
27,482
+18,520
| +207% | +$113K | ﹤0.01% | 2387 |
|
2016
Q3 | $49K | Buy |
+8,962
| New | +$49K | ﹤0.01% | 2728 |
|
2016
Q2 | – | Sell |
-14,213
| Closed | -$28K | – | 4010 |
|
2016
Q1 | $28K | Sell |
14,213
-201,229
| -93% | -$396K | ﹤0.01% | 2705 |
|
2015
Q4 | $1.08M | Buy |
215,442
+37,853
| +21% | +$189K | ﹤0.01% | 1325 |
|
2015
Q3 | $889K | Buy |
177,589
+73,982
| +71% | +$370K | ﹤0.01% | 1472 |
|
2015
Q2 | $829K | Sell |
103,607
-8,410
| -8% | -$67.3K | ﹤0.01% | 1571 |
|
2015
Q1 | $447K | Buy |
112,017
+101,472
| +962% | +$405K | ﹤0.01% | 1970 |
|
2014
Q4 | $31K | Buy |
10,545
+1,010
| +11% | +$2.97K | ﹤0.01% | 3241 |
|
2014
Q3 | $19K | Sell |
9,535
-10,446
| -52% | -$20.8K | ﹤0.01% | 3442 |
|
2014
Q2 | $79K | Buy |
19,981
+6,302
| +46% | +$24.9K | ﹤0.01% | 2839 |
|
2014
Q1 | $69K | Buy |
13,679
+5,615
| +70% | +$28.3K | ﹤0.01% | 2981 |
|
2013
Q4 | $40K | Buy |
8,064
+3,041
| +61% | +$15.1K | ﹤0.01% | 3485 |
|
2013
Q3 | $20K | Sell |
5,023
-6,548
| -57% | -$26.1K | ﹤0.01% | 3493 |
|
2013
Q2 | $50K | Buy |
+11,571
| New | +$50K | ﹤0.01% | 3343 |
|